Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms

Journal of Clinical Investigation

Volumn 112, Issue 7, 2003, Pages 989-998

  Haga, Sanae ^a   Terui, Keita ^a   Zhang, Hui Qi ^a   Enosawa, Shin ^a   Ogawa, Wataru ^b   Inoue, Hiroshi ^b   Okuyama, Torayuki ^c   Takeda, Kiyoshi ^d   Akira, Shizuo ^d   Ogino, Tetsuya ^e   Irani, Kaikobad ^f   Ozaki, Michitaka ^a,e  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e OKAYAMA UNIVERSITY   (Japan)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DNA; FAS LIGAND; FLICE INHIBITORY PROTEIN; MESSENGER RNA; PROTEIN BCL 2; PROTEIN BCL XL; STAT3 PROTEIN; APEX1 PROTEIN, MOUSE; CARRIER PROTEIN; CASP3 PROTEIN, MOUSE; CASP8 PROTEIN, MOUSE; CASP9 PROTEIN, MOUSE; CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; CFLAR PROTEIN, MOUSE; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; DNA BINDING PROTEIN; FAS ANTIGEN; INTERLEUKIN 6; LYASE; REACTIVE OXYGEN METABOLITE; SIGNAL PEPTIDE; STAT3 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVITY; ENZYME ASSAY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; KNOCKOUT MOUSE; LIVER CELL CULTURE; LIVER INJURY; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REPORTER GENE; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL PROTECTION; LIVER; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CARBON-OXYGEN LYASES; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CYTOPROTECTION; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; DNA-BINDING PROTEINS; INTERLEUKIN-6; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; MALE; MICE; MICE, INBRED C57BL; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 0242348793     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200317970     Document Type: Article

References (49)

1. Damell, J.E., Jr. 1997. STATs and gene regulation. Science. 277:1630-1635.
2. Schuringa, J.J., Jonk, L.J., Dokter, W.H., Vellenga, E., and Kruijer W. 2000. Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components. Biochem. J. 347:89-96.
3. Leu, J.I., Crissey, M.A., Leu, J.P., Ciliberto, G., and Taub, R. 2001. Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury. Mol. Cell. Biol. 21:414-424.
4. Schuringa, J.J., van der Schaaf, S., Vellenga, E., Eggen, B.J., and Kruijer, W. 2002. LIF-induced STAT3 signaling in murine versus human embryonal carcinoma (EC) cells. Exp. Cell Res. 274:119-129.
5. Levy, D.E., and Lee, C.K. 2002. What does Stat3 do? J. Clin. Invest. 109:1143-1148. doi:10.1172/JCI200215650.
6. Zhong, Z., Wen, Z., and Darnell, J.E. 1994. Stat3: a STAT family, member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science. 264:95-98.
7. Lutticken, C., et al. 1994. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science. 263:89-92.
8. Hirano, T., Ishihara, K., and Hibi, M. 2000. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene. 19:2548-2556.
9. Bowman, T., Garcia, R., Turkson, J., and Jove, R. 2000. STATs in oncogenesis. Oncogene. 19:2474-2488.
10. Takeda, K., et al. 1997. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. U. S. A. 94:3801-3804.
11. Li, W., Liang, X., Kellendonk, C., Poli, V., and Taub, R. 2002. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J. Biol. Chem. 277:28411-28417.
12. Debonera, F., et al. 2001. Activation of interleukin-6/STAT3 and liver regeneration following transplantation. J. Surg. Res. 96:289-295.
13. Shen, Y., Devgan, G., Darnell, J.E., and Bromberg, J.F. 2001. Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Srat1. Proc. Natl. Acad. Sci. U. S. A. 98:1543-1548.
14. Grandis, J.R., et al. 2000. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc. Natl. Acad. Sci. U. S. A. 97:4227-4232.
15. Takeda, K., et al. 1998. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol. 161:4652-4660.
16. Nagata, S. 1999. Fas ligand-induced apoptosis. Annu. Rev. Genet. 33:29-55.
17. Matsumura, H., et al. 2000. Necrotic death pathway in Fas receptor signaling. J. Cell Biol. 151:1247-1256.
18. Siegmund, D., et al. 2001. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway. J. Biol. Chem. 276:32585-32590.
19. Kovalovich, K., et al. 2001. Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J. Biol. Chem. 276:26605-26613.
20. Budd, R.C. 2002. Death receptors couple to both cell proliferation and apoptosis. J. Clin. Invest. 109:437-442. doi:10.1172/JCI200215077.
21. Pinkoski, M.J., Brunner, T., Green, D.R., and Lin, T. 2000. Fas and Fas ligand in gut and liver. Am. J. Physiol. Gastrointest. Liver Physiol. 278:G354-G366.
22. Galle, P.R., et al. 1995. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182:1223-1230.
23. Kanzler, S., and Galle, P.R. 2000. Apoptosis and the liver. Semin. Cancer Biol. 10:173-184.
24. Faubion, W.A., et al. 1999. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J. Clin. Invest. 103:137-145.
25. Bromberg, J., and Darnell, J.E. 2000. The role of STATs in transcriptional control and their impact on cellular function. Oncogene. 19:2468-2473.
26. Ozaki, M., Suzuki, S., and Irani, K. 2002. Redox factor-1/APE suppresses oxidative stress by inhibiting the rac1 GTPase. FASEB J. 16:889-890.
27. Yamakawa, Y., et al. 2000. Interaction of platelet activating factor, reactive oxygen species generated by xanthine oxidase, and leukocytes in the generation of hepatic injury after shock/resuscitation. Ann. Surg. 231:387-398.
28. Daemen, M.A.R.C., et al. 1999. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J. Clin. Invest. 104:541-549.
29. Yakar, S., et al. 1999. Normal growth and development in the absence of hepatic insulin-like growth factor 1. Proc. Natl. Acad. Sci. U. S. A. 96:7324-7329.
30. Ozaki, M., et al. 2000. Inhibition of the Rac1 GTPase protects against nonlethal ischemia/reperfusion-induced necrosis and apoptosis in vivo. FASEB J. 14:418-429.
31. Grosch, S., Fritz, G., and Kaina, B. 1998. Apurinic endonuclease (Ref-1) is induced in mammalian cells by oxidative stress and involved in clastogenic adaptation. Cancer Res. 58:4410-4416.
32. Grosch, S., and Kaina, B. 1999. Transcriptional activation of apurinic/ apyrimidinic endonuclease (Ape, Ref-1) by oxidative stress requires CREB. Biochem. Biophys. Res. Commun. 261:859-863.
33. Galun, E., Zeira, E., Pappo, O., Peters, M., and Rose-John, S. 2000. Liver regeneration induced by a designer human IL-6/sIL-6R fusion protein reverses severe hepatocellular injury. FASEB J 14:1979-1987.
34. Peters, M., et al. 2000. Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration. Gastroenterology. 119:1663-1671.
35. Hecht, N., et al. 2001. Hyper-IL-6 gene therapy reverses fulminant hepatic failure. Mol. Ther. 3:683-687.
36. Malassagne, B., et al. 2001. The superoxide dismutase mimetic MnTBAP prevents Fas-induced acute liver failure in the mouse. Gastroenterology. 121:1451-1459.
37. Suzuki, Y., Ono, Y., and Hirabayashi, Y. 1998. Rapid and specific reactive oxygen species generation via NADPH oxidase activation during Fas-mediated apoptosis. FEBS Lett. 425:209-212.
38. Giardina, C., Boulares, H., and Inan, M.S. 1999. NSAIDs and butyrate sensitize a human colorectal cancer cell line to TNF-alpha and Fas ligation: the role of reactive oxygen species. Biochem. Biophys. Acta. 1448:425-438.
39. Jayanthi, S., Ordonez, S., McCoy, M.T., and Cadet, J.L. 1999. Dual mechanism of Fas-induced cell death in neuroglioma cells: a role for reactive oxygen species. Brain Res. Mol. Brain Res. 72:158-165.
40. Gulbins, E., et al. 1996. Fas-induced programmed cell death is mediated by a Ras-regulated O2-synthesis. Immunology. 89:205-212.
41. Demple, B., Herman, T., and Chen, D. 1991. Cloning and expression of APE, the cDNA encoding the major human apurinic endonuclease: definition of family of DNA repair enzymes. Proc. Natl. Acad. Sci. U. S. A. 88:11450-11454.
42. Miromo, K., et al. 1994. Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-kappa B in vitro. Gene. 145:197-203.
43. Jayaraman, L., et al. 1997. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev. 11:558-570.
44. Huang, L.E., Arany, Z., Livingston, D.M., and Bunn, H.F. 1996. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J. Biol. Chem. 271:32253-32259.
45. Nakamura, H., Nakamura, K., and Yodoi, J. 1997. Redox regulation of cellular activation. Annu. Rev. Immunol. 15:351-369.
46. Negoro, S., et al. 2001. Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase. Circulation. 104:979-981.
47. Nakagami, H., et al. 2001. Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells. Hypertension. 37:581-586.
48. Ozaki, M., Haga, S., Zhang, H., Irani, K., and Suzuki, S. 2003. Inhibition of hypoxia/reoxygenation-induced oxidative stress in HGF-stimulated anti-apoptotic signaling: role of PI3-K and Akt kinase upon rac1. Cell Death Differ. 10:508-515.
49. Ping, P., et al. 2002. Formation of protein kinase Cε-Lck signaling modules confers cardioprotection. J. Clin. Invest. 109:499-507. JCI200213200.